Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles

被引：0

作者：

Goepfert, P. ^{[1
]}

Elizaga, M. ^{[2
]}

Montefiori, D. ^{[3
]}

Hural, J. ^{[2
]}

DeRosa, S. ^{[2
]}

Tomaras, G. ^{[3
]}

Seaton, K. ^{[3
]}

Sato, A. ^{[2
]}

Ouedraogo, L. ^{[4
]}

Donastorg, Y. ^{[5
]}

Cardinali, M. ^{[4
]}

Lama, J. ^{[6
]}

Baden, L. ^{[7
]}

Keefer, M. ^{[8
]}

McElrath, J. ^{[2
]}

Kalams, S. ^{[9
]}

Robinson, H. ^{[10
]}

机构：

[1] Univ Alabama Birmingham, Birmingham, AL USA

[2] Fred Hutchinson Canc Res Inst, Seattle, WA 98104 USA

[3] Duke Univ, Durham, NC USA

[4] NIAID, Vaccine Clin Res Branch, Bethesda, MD 20892 USA

[5] Unidad Vacunas IDCP COIN DIGECITSS, Santo Dominago, Dominican Rep

[6] Asociac Civil IMPACTA Salud & Educ, Lima, Peru

[7] Brigham & Womens Hosp, Boston, MA 02115 USA

[8] Univ Rochester, Rochester, NY USA

[9] Vanderbilt Univ, Nashville, TN USA

[10] GeoVax Inc, Smyma, CA USA

来源：

RETROVIROLOGY | 2012年 / 9卷

关键词：

Vaccinia; Modify Vaccinia Ankara Virus; Avidity Index; Antibody Avidity; Immunogenicity Testing;

D O I：

10.1186/1742-4690-9-S2-O56

中图分类号：

Q93 [微生物学];

学科分类号：

071005 ; 100705 ;

摘要：

引用

页数：1

共 50 条

[1] Phase 2a safety and immunogenicity testing of DNA and recombinant modified vaccinia ankara virus vaccines expressing virus-like particles
P Goepfert
M Elizaga
D Montefiori
J Hural
S DeRosa
G Tomaras
K Seaton
A Sato
L Ouedraogo
Y Donastorg
M Cardinali
J Lama
L Baden
M Keefer
J McElrath
S Kalams
H Robinson
Retrovirology, 9
[2] Phase 1 Safety and Immunogenicity Testing of DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-like Particles
Goepfert, Paul A.
Elizaga, Marnie L.
Sato, Alicia
Qin, Li
Cardinali, Massimo
Hay, Christine M.
Hural, John
DeRosa, Stephen C.
DeFawe, Olivier D.
Tomaras, Georgia D.
Montefiori, David C.
Xu, Yongxian
Lai, Lilin
Kalams, Spyros A.
Baden, Lindsey R.
Frey, Sharon E.
Blattner, William A.
Wyatt, Linda S.
Moss, Bernard
Robinson, Harriet L.
JOURNAL OF INFECTIOUS DISEASES, 2011, 203 (05): : 610 - 619
[3] Ty virus-like particles, DNA vaccines and Modified Vaccinia Virus Ankara; Comparisons and combinations
Gilbert, SC
Schneider, J
Plebanski, M
Hannan, CM
Blanchard, TJ
Smith, GL
Hill, AVS
BIOLOGICAL CHEMISTRY, 1999, 380 (03) : 299 - 303
[4] Recombinant Modified Vaccinia Virus Ankara Generating Ebola Virus-Like Particles
Schweneker, Marc
Laimbacher, Andrea S.
Zimmer, Gert
Wagner, Susanne
Schraner, Elisabeth M.
Wolferstaetter, Michael
Klingenberg, Marieken
Dirmeier, Ulrike
Steigerwald, Robin
Lauterbach, Henning
Hochrein, Hubertus
Chaplin, Paul
Suter, Mark
Hausmanna, Juergen
JOURNAL OF VIROLOGY, 2017, 91 (11)
[5] Specificity and 6-Month Durability of Immune Responses Induced by DNA and Recombinant Modified Vaccinia Ankara Vaccines Expressing HIV-1 Virus-Like Particles
Goepfert, Paul A.
Elizaga, Marnie L.
Seaton, Kelly
Tomaras, Georgia D.
Montefiori, David C.
Sato, Alicia
Hural, John
DeRosa, Stephen C.
Kalams, Spyros A.
McElrath, M. Juliana
Keefer, Michael C.
Baden, Lindsey R.
Lama, Javier R.
Sanchez, Jorge
Mulligan, Mark J.
Buchbinder, Susan P.
Hammer, Scott M.
Koblin, Beryl A.
Pensiero, Michael
Butler, Chris
Moss, Bernard
Robinson, Harriet L.
JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (01): : 99 - 110
[6] Safety and Immunogenicity of Novel Recombinant BCG and Modified Vaccinia Virus Ankara Vaccines in Neonate Rhesus Macaques
Rosario, Maximillian
Fulkerson, John
Soneji, Shamit
Parker, Joe
Im, Eung-Jun
Borthwick, Nicola
Bridgeman, Anne
Bourne, Charles
Joseph, Joan
Sadoff, Jerald C.
Hanke, Tomas
JOURNAL OF VIROLOGY, 2010, 84 (15) : 7815 - 7821
[7] Immunogenicity and safety of defective vaccinia virus lister:: Comparison with modified vaccinia virus Ankara
Ober, BT
Brühl, P
Schmidt, M
Wieser, V
Gritschenberger, W
Coulibaly, S
Savidis-Dacho, H
Gerencer, M
Falkner, FG
JOURNAL OF VIROLOGY, 2002, 76 (15) : 7713 - 7723
[8] Vaccination with Combination DNA and Virus-Like Particles Enhances Humoral and Cellular Immune Responses upon Boost with Recombinant Modified Vaccinia Virus Ankara Expressing Human Immunodeficiency Virus Envelope Proteins
Gangadhara, Sailaja
Kwon, Young-Man
Jeeva, Subbiah
Quan, Fu-Shi
Wang, Baozhong
Moss, Bernard
Compans, Richard W.
Amara, Rama Rao
Jabbar, M. Abdul
Kang, Sang-Moo
VACCINES, 2017, 5 (04):
[9] Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
McConkey, SJ
Reece, WHH
Moorthy, VS
Webster, D
Dunachie, S
Butcher, G
Vuola, JM
Blanchard, TJ
Gothard, P
Watkins, K
Hannan, CM
Everaere, S
Brown, K
Kester, KE
Cummings, J
Williams, J
Heppner, DG
Pathan, A
Flanagan, K
Arulanantham, N
Roberts, MTM
Roy, M
Smith, GL
Schneider, J
Peto, T
Sinden, RE
Gilbert, SC
Hill, AVS
NATURE MEDICINE, 2003, 9 (06) : 729 - 735
[10] Enhanced T-cell immunogenicity of plasmid DNA vaccines boosted by recombinant modified vaccinia virus Ankara in humans
Samuel J McConkey
William H H Reece
Vasee S Moorthy
Daniel Webster
Susanna Dunachie
Geoff Butcher
Jenni M Vuola
Tom J Blanchard
Philip Gothard
Kate Watkins
Carolyn M Hannan
Simone Everaere
Karen Brown
Kent E Kester
James Cummings
Jackie Williams
D Gray Heppner
Ansar Pathan
Katie Flanagan
Nirmalan Arulanantham
Mark T M Roberts
Michael Roy
Geoffrey L Smith
Joerg Schneider
Tim Peto
Robert E Sinden
Sarah C Gilbert
Adrian V S Hill
Nature Medicine, 2003, 9 : 729 - 735

← 1 2 3 4 5 →